Microbix Historical Balance Sheet

MBX Stock

CAD 0.36 0.01 2.86%

Trend analysis of Microbix Biosystems balance sheet accounts such as Total Current Liabilities of 2.7 M provides information on Microbix Biosystems' total assets, liabilities, and equity, which is the actual value of Microbix Biosystems to its prevalent stockholders. By breaking down trends over time using Microbix Biosystems balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Microbix Biosystems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microbix Biosystems is a good buy for the upcoming year.

Microbix Biosystems Inventory

6.95 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Microbix Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Microbix Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Microbix Biosystems Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Microbix Biosystems and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Microbix currently owns. An asset can also be divided into two categories, current and non-current.

Microbix Biosystems Balance Sheet Chart

At this time, Microbix Biosystems' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 10th of December 2024, Inventory is likely to grow to about 6.9 M, while Short and Long Term Debt Total is likely to drop about 4.5 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Total Stockholder Equity Non Current Assets Total Other Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Microbix Biosystems assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Microbix Biosystems books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Microbix Biosystems balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Microbix Biosystems are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Microbix Biosystems' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	5.8M	6.6M	7.6M	4.5M
Total Assets	33.1M	35.7M	41.0M	43.1M

Short Long Term Debt Total Total Assets

Microbix Biosystems balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Non Current Liabilities Total	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.35	0.22	0.39	0.98	0.44	-0.58	-0.47	0.47	0.78	0.32	0.02	0.78	0.91	0.91	0.89	0.72	0.49	0.48	0.98	0.89	-0.18	0.4	0.22	0.71	0.81
Short Long Term Debt Total	0.35		0.27	0.76	0.18	0.8	0.39	-0.69	0.8	-0.13	0.78	0.15	-0.13	0.29	0.38	0.4	-0.26	0.18	0.95	0.42	0.04	0.47	0.79	0.63	0.66	0.47
Other Current Liab	0.22	0.27		0.29	0.17	0.08	-0.09	-0.38	0.14	0.16	0.12	0.26	0.16	0.24	0.29	0.22	0.06	0.41	0.34	0.21	0.2	0.07	0.27	0.13	0.28	0.31
Total Current Liabilities	0.39	0.76	0.29		0.27	0.74	0.28	-0.49	0.72	-0.09	0.75	0.42	-0.09	0.23	0.35	0.54	-0.13	0.52	0.8	0.39	0.09	0.69	0.33	0.59	0.68	0.44
Total Stockholder Equity	0.98	0.18	0.17	0.27		0.33	-0.72	-0.35	0.33	0.87	0.19	-0.02	0.87	0.89	0.87	0.84	0.8	0.48	0.33	0.94	0.93	-0.26	0.27	0.07	0.64	0.8
Property Plant And Equipment Net	0.44	0.8	0.08	0.74	0.33		0.29	-0.38	0.89	-0.09	0.93	0.51	-0.09	0.24	0.29	0.39	-0.19	0.03	0.82	0.53	0.06	0.39	0.6	0.69	0.55	0.41
Net Debt	-0.58	0.39	-0.09	0.28	-0.72	0.29		-0.01	0.24	-0.95	0.48	0.38	-0.95	-0.66	-0.57	-0.42	-0.91	-0.36	0.23	-0.52	-0.87	0.59	0.08	0.55	-0.21	-0.57
Retained Earnings	-0.47	-0.69	-0.38	-0.49	-0.35	-0.38	-0.01		-0.4	-0.21	-0.29	0.24	-0.21	-0.49	-0.72	-0.68	-0.07	-0.58	-0.68	-0.5	-0.37	-0.14	-0.61	-0.15	-0.83	-0.67
Accounts Payable	0.47	0.8	0.14	0.72	0.33	0.89	0.24	-0.4		-0.03	0.86	0.38	-0.03	0.26	0.31	0.42	-0.08	0.08	0.87	0.53	0.11	0.24	0.7	0.71	0.52	0.42
Cash	0.78	-0.13	0.16	-0.09	0.87	-0.09	-0.95	-0.21	-0.03		-0.29	-0.35	1.0	0.84	0.78	0.62	0.93	0.45	0.01	0.74	0.97	-0.5	0.12	-0.38	0.41	0.72
Non Current Assets Total	0.32	0.78	0.12	0.75	0.19	0.93	0.48	-0.29	0.86	-0.29		0.62	-0.29	0.07	0.13	0.31	-0.34	-0.05	0.79	0.36	-0.12	0.47	0.53	0.89	0.44	0.23
Non Currrent Assets Other	0.02	0.15	0.26	0.42	-0.02	0.51	0.38	0.24	0.38	-0.35	0.62		-0.35	-0.28	-0.25	-0.01	-0.36	-0.11	0.19	0.02	-0.3	0.38	-0.08	0.6	-0.08	-0.2
Cash And Short Term Investments	0.78	-0.13	0.16	-0.09	0.87	-0.09	-0.95	-0.21	-0.03	1.0	-0.29	-0.35		0.84	0.78	0.62	0.93	0.45	0.01	0.74	0.97	-0.5	0.12	-0.38	0.41	0.72
Net Receivables	0.91	0.29	0.24	0.23	0.89	0.24	-0.66	-0.49	0.26	0.84	0.07	-0.28	0.84		0.92	0.77	0.8	0.49	0.4	0.91	0.92	-0.26	0.42	-0.02	0.65	0.79
Common Stock Shares Outstanding	0.91	0.38	0.29	0.35	0.87	0.29	-0.57	-0.72	0.31	0.78	0.13	-0.25	0.78	0.92		0.92	0.68	0.67	0.48	0.9	0.89	-0.16	0.43	0.0	0.83	0.88
Inventory	0.89	0.4	0.22	0.54	0.84	0.39	-0.42	-0.68	0.42	0.62	0.31	-0.01	0.62	0.77	0.92		0.58	0.73	0.53	0.84	0.78	-0.02	0.34	0.21	0.87	0.82
Other Current Assets	0.72	-0.26	0.06	-0.13	0.8	-0.19	-0.91	-0.07	-0.08	0.93	-0.34	-0.36	0.93	0.8	0.68	0.58		0.43	-0.07	0.66	0.91	-0.58	0.03	-0.34	0.33	0.6
Other Stockholder Equity	0.49	0.18	0.41	0.52	0.48	0.03	-0.36	-0.58	0.08	0.45	-0.05	-0.11	0.45	0.49	0.67	0.73	0.43		0.28	0.42	0.56	0.19	-0.04	-0.17	0.7	0.61
Total Liab	0.48	0.95	0.34	0.8	0.33	0.82	0.23	-0.68	0.87	0.01	0.79	0.19	0.01	0.4	0.48	0.53	-0.07	0.28		0.54	0.19	0.32	0.83	0.64	0.74	0.6
Property Plant And Equipment Gross	0.98	0.42	0.21	0.39	0.94	0.53	-0.52	-0.5	0.53	0.74	0.36	0.02	0.74	0.91	0.9	0.84	0.66	0.42	0.54		0.85	-0.18	0.5	0.22	0.7	0.8
Total Current Assets	0.89	0.04	0.2	0.09	0.93	0.06	-0.87	-0.37	0.11	0.97	-0.12	-0.3	0.97	0.92	0.89	0.78	0.91	0.56	0.19	0.85		-0.4	0.22	-0.22	0.58	0.81
Short Term Debt	-0.18	0.47	0.07	0.69	-0.26	0.39	0.59	-0.14	0.24	-0.5	0.47	0.38	-0.5	-0.26	-0.16	-0.02	-0.58	0.19	0.32	-0.18	-0.4		-0.16	0.37	0.15	-0.16
Non Current Liabilities Total	0.4	0.79	0.27	0.33	0.27	0.6	0.08	-0.61	0.7	0.12	0.53	-0.08	0.12	0.42	0.43	0.34	0.03	-0.04	0.83	0.5	0.22	-0.16		0.46	0.54	0.56
Intangible Assets	0.22	0.63	0.13	0.59	0.07	0.69	0.55	-0.15	0.71	-0.38	0.89	0.6	-0.38	-0.02	0.0	0.21	-0.34	-0.17	0.64	0.22	-0.22	0.37	0.46		0.24	0.03
Common Stock Total Equity	0.71	0.66	0.28	0.68	0.64	0.55	-0.21	-0.83	0.52	0.41	0.44	-0.08	0.41	0.65	0.83	0.87	0.33	0.7	0.74	0.7	0.58	0.15	0.54	0.24		0.89
Common Stock	0.81	0.47	0.31	0.44	0.8	0.41	-0.57	-0.67	0.42	0.72	0.23	-0.2	0.72	0.79	0.88	0.82	0.6	0.61	0.6	0.8	0.81	-0.16	0.56	0.03	0.89

Click cells to compare fundamentals

Microbix Biosystems Account Relationship Matchups

Microbix Biosystems balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.6M	28.8M	33.1M	35.7M	41.0M	43.1M
Short Long Term Debt Total	6.2M	7.7M	5.8M	6.6M	7.6M	4.5M
Other Current Liab	1.5M	1.8M	1.8M	2.0M	2.3M	1.3M
Total Current Liabilities	4.1M	5.2M	2.7M	4.3M	5.0M	2.7M
Total Stockholder Equity	6.6M	18.6M	24.9M	24.6M	28.3M	29.7M
Property Plant And Equipment Net	7.4M	8.1M	8.9M	8.9M	10.3M	5.8M
Net Debt	6.1M	(2.3M)	(7.7M)	(5.0M)	(5.7M)	(5.4M)
Retained Earnings	(41.9M)	(38.7M)	(36.9M)	(36.9M)	(33.2M)	(31.6M)
Accounts Payable	1.5M	1.8M	1.8M	2.1M	2.4M	1.5M
Cash	92.7K	10.0M	13.5M	11.6M	13.3M	14.0M
Non Current Assets Total	9.1M	9.7M	10.7M	13.4M	15.4M	9.0M
Cash And Short Term Investments	92.7K	10.0M	13.5M	11.6M	13.3M	14.0M
Net Receivables	1.9M	4.2M	3.1M	4.2M	4.8M	5.0M
Common Stock Shares Outstanding	104.8M	141.7M	141.7M	137.9M	158.6M	166.5M
Liabilities And Stockholders Equity	15.6M	28.8M	33.1M	35.7M	41.0M	43.1M
Inventory	4.3M	4.4M	5.3M	5.8M	6.6M	6.9M
Other Current Assets	220.1K	495.0K	546.3K	767.5K	882.6K	926.7K
Other Stockholder Equity	13.2M	13.6M	9.6M	10.2M	11.8M	11.5M
Total Liab	9.0M	10.3M	8.2M	11.0M	12.7M	6.5M
Property Plant And Equipment Gross	7.4M	14.7M	16.4M	17.4M	20.0M	21.0M
Total Current Assets	6.5M	19.1M	22.4M	22.3M	25.6M	26.9M
Short Term Debt	1.3M	2.7M	267.4K	265.4K	305.2K	290.0K
Non Current Liabilities Total	4.9M	5.1M	5.6M	6.7M	7.7M	4.0M
Intangible Assets	1.7M	1.7M	1.5M	4.4M	5.1M	3.5M
Common Stock	35.4M	43.6M	49.9M	49.0M	56.4M	35.8M
Current Deferred Revenue	1.3M	742.9K	554.6K	2.0M	2.3M	2.4M
Net Tangible Assets	5.6M	4.9M	16.9M	23.4M	27.0M	28.3M
Long Term Debt	4.5M	4.1M	4.7M	5.7M	5.1M	3.8M
Short Long Term Debt	2.6M	1.1M	2.4M	111.1K	100.0K	95.0K
Property Plant Equipment	6.7M	7.4M	8.1M	8.9M	8.0M	7.4M
Long Term Debt Total	4.3M	4.9M	5.1M	5.6M	6.4M	5.5M
Capital Surpluse	9.4M	10.3M	10.7M	9.6M	11.1M	9.2M
Capital Lease Obligations	541.9K	1.2M	1.0M	854.0K	982.1K	589.3K
Net Invested Capital	12.3M	25.1M	29.8M	30.4M	35.0M	24.1M
Net Working Capital	2.4M	13.9M	19.8M	18.0M	20.6M	21.7M
Capital Stock	35.4M	43.6M	49.9M	49.0M	56.4M	45.1M

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving against Microbix Stock

0.74	RY-PM	Royal Bank	Pair Corr
0.68	BNS	Bank of Nova Scotia	Pair Corr
0.67	TD-PFI	Toronto Dominion Bank	Pair Corr
0.65	RY-PS	Royal Bank	Pair Corr
0.58	TD-PFD	Toronto Dominion Bank	Pair Corr

The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.

The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Microbix Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Microbix Historical Balance Sheet

Microbix Biosystems Inventory

6.95 Million

About Microbix Balance Sheet Analysis

Microbix Biosystems Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Non Current Assets Total

Microbix Biosystems balance sheet Correlations

Microbix Biosystems Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Microbix Biosystems balance sheet Accounts

Pair Trading with Microbix Biosystems

Moving against Microbix Stock

Other Information on Investing in Microbix Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.98	Total Assets
Property Plant And Equipment Gross	+ 0.98	Total Assets
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Total Liab	+ 0.95	Short Long Term Debt Total

Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Other Current Assets	- 0.91	Net Debt
Total Current Assets	- 0.87	Net Debt
Common Stock Total Equity	- 0.83	Retained Earnings
Common Stock Shares Outstanding	- 0.72	Retained Earnings